Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort
C Scoccianti, A Vesin, G Martel… - European …, 2012 - Eur Respiratory Soc
Nonsmall cell lung cancer samples from the European Early Lung Cancer biobank were
analysed to assess the prognostic significance of mutations in the TP53, KRAS and EGFR …
analysed to assess the prognostic significance of mutations in the TP53, KRAS and EGFR …
Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran
A Sepehr, P Tanière, G Martel-Planche, AA Zia'ee… - Oncogene, 2001 - nature.com
Extremely high rates of squamous cell carcinoma of the esophagus (SCCE) are observed in
Iran, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic …
Iran, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic …
Interactions between hepatitis B virus and aflatoxin B1: effects on p53 induction in HepaRG cells
…, P Berthillon, G Martel-Planche… - Journal of general …, 2012 - microbiologyresearch.org
Infection by hepatitis B virus (HBV) and dietary exposure to aflatoxin B 1 (AFB 1 ) are the
main risk factors for the development of chronic liver disease and hepatocellular carcinoma (…
main risk factors for the development of chronic liver disease and hepatocellular carcinoma (…
Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia
P Tanière, G Martel-Planche, D Maurici… - The American journal of …, 2001 - Elsevier
Adenocarcinoma of the esophagus (ADCE) with Barrett’s mucosa and adenocarcinoma of
the cardia (ADCC) are often reported as a single pathological entity. In this study we have …
the cardia (ADCC) are often reported as a single pathological entity. In this study we have …
[HTML][HTML] TP53 mutations, human papilloma virus DNA and inflammation markers in esophageal squamous cell carcinoma from the Rift Valley, a high-incidence area …
…, T Gheit, M Tommasino, G Martel-Planche… - BMC research …, 2011 - Springer
Background Squamous Cell Carcinoma of Esophagus is one of the most common
malignancies in both men and women in eastern and south-eastern Africa. In Kenya, clinical …
malignancies in both men and women in eastern and south-eastern Africa. In Kenya, clinical …
Mutation of TP53 and alteration of p14arf expression in EGFR-and KRAS-mutated lung adenocarcinomas
AB Cortot, M Younes, G Martel-Planche, B Guibert… - Clinical lung cancer, 2014 - Elsevier
Background In lung adenocarcinoma, inactivation of the tumor suppressor p53 may abrogate
a safeguard mechanism preventing the development of tumors with activating mutations in …
a safeguard mechanism preventing the development of tumors with activating mutations in …
[PDF][PDF] Prevalence and prognostic value of TP53 KRAS and EGFR mutations in the EUELC cohort
Field, John; Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer
Research Centre, Institute of Translational Medicine, The University of Liverpool Hainaut…
Research Centre, Institute of Translational Medicine, The University of Liverpool Hainaut…
Erratum: Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran
A Sepehr, P Tanière, G Martel-Planche, AA Zia'ee… - Oncogene, 2002 - nature.com
Extremely high rates of squamous cell carcinoma of the esophagus (SCCE) are observed in
Iran, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic …
Iran, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic …
[PDF][PDF] Évolution de l'incidence du cancer du foie à Bamako, Mali
M de Seze - academia.edu
Le Carcinome Hepato Cellulaire (CHC) est un cancer du foie hautement répandu dans le
monde, en particulier dans les régions à faibles ressources comme l'Afrique de l'Ouest. …
monde, en particulier dans les régions à faibles ressources comme l'Afrique de l'Ouest. …
Etude des relations entre les mutations EGFR/KRAS et les altérations de la voie p53/p14arf et caractérisation d'une nouvelle cible thérapeutique, le complexe …
M Younes - 2012 - theses.hal.science
Nous avons étudié, le statut de la voie p53/p14arf dans l'adénocarcinome bronchique muté
pour EGFR ou KRAS ainsi que l'impact du complexe NTS/NTSR1 sur la progression …
pour EGFR ou KRAS ainsi que l'impact du complexe NTS/NTSR1 sur la progression …